ArticleClinical infectious diseases : an official publication of the Infectious Diseases Society of America2023

First Do No Harm? Modeling Risks and Benefits of Challenge Trials for Hepatitis C Vaccine Development.

Alyssa Bilinski et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.